VBIV

HEALTHCARE

VBI Vaccines Inc

—PRE

Live · NASDAQ · May 8, Close

AI Insight

What's Moving VBIV Today?

No stock-specific AI insight has been generated for VBIV yet. Check back soon — insights are generated from recent news analysis.

Fundamentals

Market Cap$2M

P/E Ratio—

EPS$-3.54

Dividend Yield—

Dividend / Share—

ROE-4.2%

Profit Margin—

Debt / Equity—

Trading

Volume—

Avg Volume (10D)—

Shares Outstanding28.7M

VBIV News

No news articles found for VBIV yet.

Price Data

Open—

Previous Close—

Day High—

Day Low—

52 Week High$0.00

52 Week Low$0.00

Fundamentals

Market Cap$2M

P/E Ratio—

EPS$-3.54

Dividend Yield—

Dividend / Share—

ROE-4.2%

Profit Margin—

Debt / Equity—

Trading

Volume—

Avg Volume (10D)—

Shares Outstanding28.7M

About VBI Vaccines Inc

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company is headquartered in Cambridge, Massachusetts.

vbivaccines.com

Listed February 6, 2026

HEALTHCAREBIOTECHNOLOGY

Company Details

Security TypeStock

ExchangeNASDAQ

CurrencyUSD

Round Lot—

SICBIOTECHNOLOGY

CIK—

Composite FIGI—

Share Class FIGI—